Cohance Lifesciences Shareholding Pattern & Promoter Holding
Pharmaceuticals & Biotechnology · Latest pattern: Sep 2026
As of Sep 2026, promoters hold 57.48% of Cohance Lifesciences, FIIs hold 7.71%, DIIs hold 18.86% and the public holds 15.95%. Promoter holding fell by 0.01 percentage points from Jun 2026.
Get an alert when Cohance Lifesciences reports results or its shareholding changes. Free account.
Promoters
57.48%
−0.01 pp QoQ
FIIs
7.71%
+1.21 pp QoQ
DIIs
18.86%
−1.23 pp QoQ
Public
15.95%
+0.03 pp QoQ
Cohance Lifesciences shareholding, quarter by quarter
| Quarter | Promoters | FIIs | DIIs | Government | Public | Shareholders |
|---|---|---|---|---|---|---|
| Sep 2026 | 57.48% | 7.71% | 18.86% | 0.00% | 15.95% | 93,846 |
| Jun 2026 | 57.49% | 6.50% | 20.09% | 0.01% | 15.92% | 99,149 |
| Mar 2026 | 57.49% | 5.59% | 21.79% | 0.01% | 15.11% | 85,230 |
| Dec 2025 | 57.49% | 6.01% | 21.57% | 0.01% | 14.91% | 81,877 |
| Sep 2025 | 57.49% | 6.51% | 20.81% | 0.01% | 15.16% | 75,284 |
| Jun 2025 | 66.41% | 7.23% | 11.40% | 0.01% | 14.95% | 80,910 |
| Mar 2025 | 50.10% | 11.05% | 16.60% | 0.01% | 22.24% | 86,325 |
| Dec 2024 | 50.10% | 10.84% | 16.67% | 0.01% | 22.37% | 84,210 |
| Sep 2024 | 50.10% | 10.70% | 16.95% | 0.01% | 22.26% | 69,337 |
| Jun 2024 | 50.10% | 9.80% | 17.42% | 0.01% | 22.67% | 65,777 |
| Mar 2024 | 50.10% | 9.54% | 17.24% | 0.01% | 23.11% | 68,932 |
| Dec 2023 | 60.00% | 10.14% | 15.94% | 0.01% | 13.93% | 70,052 |
Promoters · FIIs (foreign institutions) · DIIs (domestic institutions) · Government · Public (retail & others). Percentages of total shares, from the quarterly pattern filed with the exchanges.
Value of the promoter stake
At a market capitalisation of ₹17.55k cr, the promoter group's 57.48% stake is worth ₹10.09k cr. A promoter group is usually a family, trust or holding company; this figure covers only this listed company and is not anyone's net worth.
Promoter holding in Pharmaceuticals & Biotechnology peers
Cohance Lifesciences shareholding: common questions
What is the promoter holding in Cohance Lifesciences?
Promoters hold 57.48% of Cohance Lifesciences as of Sep 2026. Their stake fell by 0.01 percentage points from Jun 2026.
How much do FIIs hold in Cohance Lifesciences?
Foreign institutional investors (FIIs) held 7.71% of Cohance Lifesciences in Sep 2026, +1.21 pp versus Jun 2026.
How much do mutual funds and other DIIs hold in Cohance Lifesciences?
Domestic institutional investors (DIIs), which include mutual funds and insurers, held 18.86% of Cohance Lifesciences in Sep 2026, −1.23 pp versus Jun 2026.
Is the promoter holding in Cohance Lifesciences pledged?
The latest disclosed shareholding pattern shows no pledged promoter shares in Cohance Lifesciences.
How has Cohance Lifesciences's promoter holding changed in the last year?
Promoter holding moved from 57.49% in Sep 2025 to 57.48% in Sep 2026 (−0.01 pp).
How many shareholders does Cohance Lifesciences have?
Cohance Lifesciences had 93,846 shareholders in Sep 2026, compared with 99,149 in Jun 2026.